-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A variety of commonly used drugs are out of sale, including acetaminophen tablets, gold and silver flower dew.... On October 16, the Shanghai Drug Administration announced the "Notice no. 3 on drug quality testing in 2020" (hereinafter referred to as the "Notice").
The notice said that in order to strengthen drug quality supervision and management, standardize market order, and ensure the quality and safety of listed drugs and pharmaceutical packages, the Shanghai Municipal Drug Administration organized relevant units to carry out quality sampling of drug production, operation and use units in the city.
will now be sampling 9 non-compliant products to be notified.
Of the 9 unqualified drugs, 5 are preparations, namely, Dragon Tiger Dan, acetaminophen tablets, gold and silver flower dew, glucose injections, silver tablets;
notice, the relevant drug regulatory departments at all levels have asked relevant enterprises to take risk control measures such as suspension and suspension, and investigate and punish them in accordance with the law.
It is worth noting that dansan marked as produced by Shandong Chixiang Chinese medicine tablets Co., Ltd., the production enterprise is located in the provincial bureau of the reply product label production enterprises denied production; The production enterprise retains the sample qualified, the dragon tiger man Dan marked as the production of Shanghai China Pharmaceutical Co., Ltd., the production enterprise retains the sample qualified, the label is the silver-saving tablet produced by Heilongjiang Fu and Huaxing Pharmaceutical Group Co., Ltd., and the product of the provincial bureau where the production enterprise is located indicates that the production enterprise leaves the sample qualified.
Simple to say, that is, the production enterprises to retain samples qualified, so that other channels storage or transportation problems;